Editor's Note CMS has taken the next steps in making prescription drugs more affordable for Medicare recipients, according to an October 9 report from The US Department of Health and Human Services (HHS). The proposed Medicare $2 Drug List Model, developed in line with President Biden’s Executive Order 14087, aims…
Editor's Note A recent randomized crossover trial conducted at Johns Hopkins University reveals that improper arm positioning during blood pressure measurements can lead to significant overestimation, potentially contributing to over-diagnosis of hypertension. The findings appeared in Jama Network October 7. The study, which included 133 participants, compared readings in three…
Editor's Note In the wake of Hurricane Helene and the recent Gulf Coast port strikes, hospitals are raising alarms and pursuing their own strategies for mitigating supply chain disruption even as a second hurricane—Milton—bears down on Florida. As of October 7, dozens of Florida healthcare facilities had suspended services and/or…
Editor's Note Six US companies will manufacture approximately 250 million medical gowns as part of a government effort to shore up supplies that were subject to shortages during the COVID-19 pandemic, the Associated Press (AP) reported October 3. Led by the Administration for Strategic Preparedness and Response (ASPR), the initiative…
Editor's Note The US Food and Drug Administration (FDA) has deemed Mercury Medical’s recall of Neo-Tee Resuscitators a Class 1, the most severe category indicating serious risk of injury or death. According to the agency’s October 7 announcement, the recall was motivated by potential for the inline controller to come…
Editor's Note The Association for the Advancement of Medical Instrumentation (AAMI) has entered into a partnership with the Consumer Technology Association (CTA) to develop new standards for the integration of artificial intelligence and machine learning in healthcare, according to an October 1 report in DOTmed. Formalized through a memorandum of…
Editor's Note The US Food and Drug Administration (FDA) has deemed the recall of Sentec Percussionaire’s Phasitron 5 In-Line Valve—a component of the manufacturer’s Intrapulmonary Percussive Ventilation (IPV) therapy system—a Class 1, the most severe category indicating serious risk of injury or death. According to the agency’s October 2…
Editor's Note This fall 2024 study published by the CATO Institute found that repealing Certificate-of-Need (CON) laws for ambulatory surgical centers (ASCs) would significantly increase the number of ASCs, improving patient access to affordable and high-quality care. By examining six states that repealed ASC-specific CON laws between 1991 and 2019,…
Editor's Note The US Food and Drug Administration (FDA) designated software-related recalls for Fresenius Kabi USA’s Iveni Infusion Systems and Philips Respironics Triology Evo ventilators as class 1, the most severe category indicating serious risk of injury or death. According to FDA’s October 1 announcement, Fresenius recalled the Ivenix Infusion…
Editor's Note Four consecutive months of reduced health system margins have resulted in significant layoffs and restructuring in top leadership, Becker’s Hospital Review reported September 30. According to the article, which cites Strata Decision Technology's August Healthcare Industry Financial Benchmarks report, average health system margins fell to 1.9% in August,…